Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1044 | 1010 | 1012 | 1009 | 1050 | - |
Fund Return | 4.41% | 0.96% | 1.21% | 0.31% | 0.97% | - |
Place in category | 1624 | 1328 | 1410 | 1190 | 713 | - |
% in Category | 79 | 64 | 70 | 80 | 69 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Soprarno Esse Stock A | 71.52M | 9.83 | 8.75 | 7.61 | ||
Soprarno Esse Stock B | 71.52M | 10.04 | 9.33 | 8.11 | ||
Soprarno Target 4pct Flessibile B | 49.06M | 0.48 | 0.80 | - | ||
Soprarno Target 4pct Flessibile A | 49.06M | 0.39 | 0.82 | - | ||
Soprarno Relative Value A | 42.9M | 5.27 | -2.26 | 2.46 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Cometa Reddito | 4.46B | 1.94 | 0.06 | 1.80 | ||
Arca TE Titoli Esteri | 2.76B | 0.57 | -2.22 | 2.15 | ||
Arca Strategia Globale Crescita P | 2.5B | 1.46 | 0.55 | 0.65 | ||
Foncer Bilanciato | 2.42B | 1.69 | 1.27 | 3.05 | ||
Eurizon Diversificato Etico | 2.21B | -0.79 | -1.00 | 1.32 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Italy (Republic Of) | IT0005056541 | 9.75 | - | - | |
Teva Pharmaceutical Finance Netherlands II B.V 0.38% | XS1439749109 | 3.25 | - | - | |
Societa per la Gestione di Attivita S.P.A. 2.62% | XS1951095329 | 2.86 | - | - | |
Immobiliare Grande Distribuzione S.p.a. 2.5% | XS1425959316 | 2.76 | - | - | |
Cassa Depositi e Prestiti S.p.A. | IT0005244774 | 2.70 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review